1. Home
  2. SPOK vs CADL Comparison

SPOK vs CADL Comparison

Compare SPOK & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPOK
  • CADL
  • Stock Information
  • Founded
  • SPOK 2004
  • CADL 1999
  • Country
  • SPOK United States
  • CADL United States
  • Employees
  • SPOK N/A
  • CADL N/A
  • Industry
  • SPOK Telecommunications Equipment
  • CADL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPOK Telecommunications
  • CADL Health Care
  • Exchange
  • SPOK Nasdaq
  • CADL Nasdaq
  • Market Cap
  • SPOK 318.9M
  • CADL 234.8M
  • IPO Year
  • SPOK 1992
  • CADL 2021
  • Fundamental
  • Price
  • SPOK $16.54
  • CADL $4.76
  • Analyst Decision
  • SPOK Hold
  • CADL Strong Buy
  • Analyst Count
  • SPOK 1
  • CADL 4
  • Target Price
  • SPOK $15.00
  • CADL $21.00
  • AVG Volume (30 Days)
  • SPOK 180.4K
  • CADL 864.6K
  • Earning Date
  • SPOK 04-30-2025
  • CADL 05-13-2025
  • Dividend Yield
  • SPOK 7.54%
  • CADL N/A
  • EPS Growth
  • SPOK N/A
  • CADL N/A
  • EPS
  • SPOK 0.77
  • CADL N/A
  • Revenue
  • SPOK $139,038,000.00
  • CADL N/A
  • Revenue This Year
  • SPOK $2.26
  • CADL N/A
  • Revenue Next Year
  • SPOK $0.14
  • CADL N/A
  • P/E Ratio
  • SPOK $21.51
  • CADL N/A
  • Revenue Growth
  • SPOK N/A
  • CADL N/A
  • 52 Week Low
  • SPOK $13.55
  • CADL $3.79
  • 52 Week High
  • SPOK $17.96
  • CADL $14.60
  • Technical
  • Relative Strength Index (RSI)
  • SPOK 59.93
  • CADL 41.42
  • Support Level
  • SPOK $13.55
  • CADL $4.80
  • Resistance Level
  • SPOK $16.60
  • CADL $5.34
  • Average True Range (ATR)
  • SPOK 0.61
  • CADL 0.33
  • MACD
  • SPOK 0.21
  • CADL 0.10
  • Stochastic Oscillator
  • SPOK 95.22
  • CADL 42.09

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: